Trial site
Hirosaki University Hospital
- 15running trials
- 6closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease4 trials
- Prostate cancer3 trials
- Ulcerative colitis3 trials
- Bladder cancer2 trials
- Heart failure2 trials
- Lung cancer2 trials
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Depression1 trial
- Ovarian cancer1 trial
- Phase
- Phase 312 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Active, not recruiting8 trials
- Completed6 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Eli Lilly and Company3 trials
- Takeda2 trials
- ARCAGY/ GINECO GROUP1 trial
- Janssen Pharmaceutical K.K.1 trial
- and 8 more
Running trials
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder
Recruiting
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Recruiting
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Recruiting
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Depression1 recruiting
- Heart failure1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026